This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Gregory K. Bell

Group Vice President and Life Sciences Practice Leader

Dr. Bell frequently testifies as an expert witness on damages in intellectual property, finance, and antitrust litigation in courts and arbitration proceedings in North America, Europe, Asia, and Australia.

Dr. Bell’s business consulting engagements focus on the economics of business strategy, working with firms to develop sustainable competitive advantages in specific product markets. He has led numerous projects concerning game theory and competitive strategy, global launch strategy, product pricing and positioning, capital budgeting and real options, and cost-benefit analyses.

Related Capabilities
Related Capabilities

Selected Engagements

  • 01
    ANDA challenge - Shire, Sanofi-Aventis, and Firazyr
    Shire, Sanofi-Aventis and Firazyr CRA consultants advised counsel to Shire Orphan Therapies, LLC (Shire) and Sanofi-Aventis Deutschland GMBH (Sanofi-Aventis)...
    View engagement
  • 02
    CRA expert testifies at trial on behalf of Church & Dwight in false advertising matter
    CRA advised counsel on behalf of Church & Dwight Co., Inc. to determine damages relating to a false advertising matter under the Lanham Act. The Court...
    View engagement
  • 03
    Endo and Opana ER ANDA challenge
    CRA consultants supported Endo International plc (Endo) in its successful challenge of products that infringed on its patents covering Opana® Extended Release...
    View engagement

Latest Insights

Recent Events

Credentials

Get In Touch
Gregory K. Bell
Boston +1-617-425-3357 gbell@crai.com